Skip to main content

Table 1 Baseline characteristics of 100 COVID-19 patients

From: The correlation between IgM and IgG antibodies with blood profile in patients infected with severe acute respiratory syndrome coronavirus

 

No (%)

Total (N = 100)

Mild (N = 22)

Moderate (N = 38)

Severe (N = 40)

p-value

Age, y, median (IQR)

50 (37.25-58.75)

43 (35.5–50)

52.5 (37.75–59.25)

51.5 (38.25–62.5)

0.198

Sex

Female

Male

48 (48%)

52 (52%)

13 (59%)

9 (41%)

18 (47.3%)

20 (52.7%)

17 (42.5%)

23 (57.5%)

0.455

Normal(BMI < 25)

Overweight(25 < BMI < 30)

obesity(BMI > 30)

22 (22%)

40 (40%)

38 (38%)

11 (50%)

5 (22.7%)

6 (27.3%)

5 (13.2%)

20 (52.6%)

13 (34.2%)

6 (15%)

15 (37.5%)

19 (47.5%)

0.05

Blood group

A+

A−

B+

B−

AB+

AB−

O+

O−

29(29%)

4(4%)

24(24%)

2(2%)

11(11%)

1(1%)

28 (28%)

1(1%)

5 (23%)

0

4 (18%)

1(4.5%)

3 (14%)

1(4.5%)

7 (32%)

1(4.5%)

11 (29%)

2 (5%)

10 (26%)

1(2.6%)

5 (13%)

0

9 (23%)

0

13 (32.5%)

2(5%)

11(27.5%)

0

3 (7.5%)

0

12 (30%)

0

0.386

Diabetic

37 (37%)

5 (22.7%)

16 (42.1%)

16 (40%)

0.286

Hypertension

32 (32%)

4 (18%)

11 (29%)

17 (42.5%)

 

Cardiovascular disease

15 (15%)

3 (13.6%)

3 (7.9%)

9 (22.5%)

0.192

Organ failure

25 (25%)

4 (18.2%)

11(28.9%)

10 (25%)

0.65

Asthma

14 (14%)

4 (18.2%)

4 (10.5%)

6(15%)

0.685

Signs and symptoms

 

Fever (℃)

< 37.3

37.3-39.0

> 39.0

37 (37%)

51 (51%)

12 (12%)

15 (68%)

6 (27%)

1 (4.5%)

13 (34%)

21 (55%)

4 (10%)

9 (22.5%)

24 (60%)

7 (17.5%)

0.009

SPO2

95-100%

90–94%

< 90

37(37%)

52(52%)

11(11%)

22 (100%)

13(34%)

24(63%)

1(3%)

2(5%)

28(70%)

10 (25%)

 

Fatigue

87 (87%)

20 (90.9%)

32 (84.2%)

35 (87.5%)

0.753

Muscle soreness

78 (78%)

17 (77.3%)

24 (63.2%)

37 (92.5%)

0.007

Chills

81 (81%)

18 (81.8%)

26 (68.4%)

37 (92.5%)

0.025

Sore throat

36 (36%)

8 (36%)

14 (37%)

14 (35%)

0.985

Shortness of breath

64 (64%)

10 (45%)

22 (58%)

32 (80%)

0.015

Cough

69 (69%)

16 (73%)

24 (63%)

29 (72.5%)

0.613

Chest pain

50 (50%)

8 (36.4%)

19 (50%)

23 (57.5%)

0.281

Headache

52 (52%)

14 (63.6%)

22 (57.9%)

16 (40%)

0.133

Nausea

36 (36%)

9 (40.9%)

14 (36.8%)

13 (32.5%)

0.797

vomiting

19 (19%)

5 (22.7%)

7 (18.4%)

7 (17.5%)

0.876

diarrhea

37 (37%)

9 (40.9%)

11(28.9%)

17 (42.5%)

0.423

Loss of consciousness

17 (17%)

0

7 (18.4%)

9 (22.5%)

0.041

Visual impairment

22 (22%)

2 (9.1%)

8 (21.1%)

12 (30%)

0.161

Odor disorder

53 (53%)

13(59.1%)

14 (36.8%)

26 (65%)

0.036

Anorexia

61 (61%)

9 (40.9%)

23 (60.5%)

30 (75%)

0.029

Abdominal pain

22 (22%)

7 (31.8%)

7 (18.4%)

8 (20%)

0.446

Taste disorder

39(39%)

6(27.3%)

11(28.9%)

22(55%)

0.027